Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiretrovirals as antimalarial agents.

Tina S Skinner-Adams1, James S McCarthy, Donald L Gardiner

  • 1Malaria Biology Laboratory, Australian Centre for International and Tropical Health and Nutrition, Queensland Institute of Medical Research and School of Population Health, University of Queensland, St. Lucia, Queensland, Australia.

The Journal of Infectious Diseases
|November 6, 2004
PubMed
Summary

Certain HIV protease inhibitors, including saquinavir, ritonavir, and indinavir, directly inhibit the growth of malaria parasites (Plasmodium falciparum) in laboratory settings. This discovery is crucial for regions with high rates of HIV and malaria coinfection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of the BALatrine intervention on soil-transmitted helminth infections in Central Java, Indonesia: a cluster-randomised controlled trial.

Nature communications·2026
Same author

Latent cytomegalovirus disrupts innate NK cell responses to P. falciparum and impairs parasite control in first infection in adults.

PLoS pathogens·2026
Same author

Mapping the global distribution and spread of the <i>Plasmodium vivax</i>-associated virus MaRNAV-1.

Virus evolution·2026
Same author

Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria.

Medicinal research reviews·2026
Same author

Relationship between antibody avidity, Fc-mediated functional activity and longevity of malaria vaccine responses in clinical trials.

Frontiers in immunology·2026
Same author

GID/CTLH E3 ligase complex control cell fate programs for sexual development of Plasmodium falciparum.

Nature communications·2026

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Tropical Medicine

Background:

  • Antiretroviral protease inhibitors are used to treat HIV infection.
  • Emerging evidence suggests these drugs may influence malaria outcomes.
  • Understanding drug interactions is critical in coinfected populations.

Purpose of the Study:

  • To investigate the antimalarial activity of commonly used antiretroviral agents.
  • To determine if specific HIV protease inhibitors directly inhibit Plasmodium falciparum growth.
  • To assess the relevance of these findings in clinical contexts.

Main Methods:

  • In vitro testing of six antiretroviral agents against Plasmodium falciparum.
  • Evaluation of drug effects at clinically relevant concentrations.

Related Experiment Videos

  • Review of existing literature on protease inhibitor effects on parasite cytoadherence and phagocytosis.

    • Main Results:

    • Saquinavir, ritonavir, and indinavir demonstrated direct inhibition of Plasmodium falciparum growth in vitro.
    • These effects were observed at concentrations achievable in patients.
    • Previous findings on cytoadherence and phagocytosis were corroborated.

    Conclusions:

    • Specific human immunodeficiency virus (HIV)-1 protease inhibitors possess direct antimalarial activity.
    • These findings have significant implications for managing malaria and HIV coinfection in sub-Saharan Africa.
    • Further research into these drug interactions is warranted for therapeutic strategies.